RNA binding protein-mediated post-transcriptional gene regulation in medulloblastoma

Rebecca Bish, Christine Vogel

Research output: Contribution to journalShort survey

Abstract

Medulloblastoma, the most common malignant brain tumor in children, is a disease whose mechanisms are now beginning to be uncovered by high-throughput studies of somatic mutations, mRNA expression patterns, and epigenetic profiles of patient tumors. One emerging theme from studies that sequenced the tumor genomes of large cohorts of medulloblastoma patients is frequent mutation of RNA binding proteins. Proteins which bind multiple RNA targets can act as master regulators of gene expression at the post-transcriptional level to co-ordinate cellular processes and alter the phenotype of the cell. Identification of the target genes of RNA binding proteins may highlight essential pathways of medulloblastomagenesis that cannot be detected by study of transcriptomics alone. Furthermore, a subset of RNA binding proteins are attractive drug targets. For example, compounds that are under development as anti-viral targets due to their ability to inhibit RNA helicases could also be tested in novel approaches to medulloblastoma therapy by targeting key RNA binding proteins. In this review, we discuss a number of RNA binding proteins, including Musashi1 (MSI1), DEAD (Asp-Glu-Ala-Asp) box helicase 3 X-linked (DDX3X), DDX31, and cell division cycle and apoptosis regulator 1 (CCAR1), which play potentially critical roles in the growth and/or maintenance of medulloblastoma.

Original languageEnglish (US)
Pages (from-to)357-364
Number of pages8
JournalMolecules and Cells
Volume37
Issue number5
DOIs
StatePublished - May 2014

Keywords

  • Medulloblastoma
  • Pediatric cancer
  • RNA helicase
  • Translation regulation

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'RNA binding protein-mediated post-transcriptional gene regulation in medulloblastoma'. Together they form a unique fingerprint.

  • Cite this